Clinical Trial Update: Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP Study ) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating BE1116 in patients with traumatic injury and acute major bleeding was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Injury

Drugs mentioned

• BE1116

Snippet

Sponsor: CSL Behring | Conditions: Traumatic Injury | Phase 3 | Status: TERMINATED | Results posted: 2025-11-10